Showing results (31-40 of 63) with videos related to

Sort By:
Pageof 7
The Journal of Neuroscience : the Official Journal of the Society for Neuroscience|May 21, 2004
Independent functions of hsp90 in neurotransmitter release and in the continuous synaptic cycling of AMPA receptorsNashaat Z Gerges, Irwin C Tran, Donald S Backos, et al.
Frontiers in Immunology|December 17, 2020
Computational Modeling of NLRP3 Identifies Enhanced ATP Binding and Multimerization in Cryopyrin-Associated Periodic SyndromesJenny Mae Samson, Dinoop Ravindran Menon, Prasanna K Vaddi, et al.
Journal of Cellular Biochemistry|July 7, 2020
4-Hydroxy-2-nonenal attenuates 8-oxoguanine DNA glycosylase 1 activityGuodong Pan, Mandar Deshpande, Haiyan Pang, et al.
Nature Neuroscience|March 4, 2008
Motor protein-dependent transport of AMPA receptors into spines during long-term potentiationSusana S Correia, Silvia Bassani, Tyler C Brown, et al.
Bioorganic & Medicinal Chemistry|October 10, 2020
10-N-heterocylic aryl-isoxazole-amides (AIMs) have robust anti-tumor activity against breast and brain cancer cell lines and useful fluorescence propertiesMatthew J Weaver, Sascha Stump, Michael J Campbell, et al.
Molecular Pharmacology|August 17, 2018
Compensatory Expression of Nur77 and Nurr1 Regulates NF-κB-Dependent Inflammatory Signaling in AstrocytesKatriana A Popichak, Sean L Hammond, Julie A Moreno, et al.
Molecular Pharmacology|April 1, 2014
19-substituted benzoquinone ansamycin heat shock protein-90 inhibitors: biological activity and decreased off-target toxicityChuan-Hsin Chang, Derek A Drechsel, Russell R A Kitson, et al.
Molecular Endocrinology (Baltimore, Md.)|August 8, 2014
Diindolylmethane analogs bind NR4A1 and are NR4A1 antagonists in colon cancer cellsSyng-Ook Lee, Xi Li, Erik Hedrick, et al.
Molecular Cancer Therapeutics|January 2, 2016
Structure-Based Screen Identification of a Mammalian Ste20-like Kinase 4 (MST4) Inhibitor with Therapeutic Potential for Pituitary TumorsWeipeng Xiong, Christopher J Matheson, Mei Xu, et al.
Chemico-Biological Interactions|January 26, 2013
ALDH16A1 is a novel non-catalytic enzyme that may be involved in the etiology of gout via protein-protein interactions with HPRT1Vasilis Vasiliou, Monica Sandoval, Donald S Backos, et al.
Pageof 7